US Stock MarketDetailed Quotes

Lineage Cell Therapeutics (LCTX)

Watchlist
  • 1.550
  • -0.010-0.64%
Close Apr 24 16:00 ET
  • 1.570
  • +0.020+1.30%
Post 19:53 ET
386.09MMarket Cap-5.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lineage Cell Therapeutics (LCTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
53.24%14.56M
130.40%6.61M
-2.59%3.68M
96.38%2.77M
4.02%1.5M
6.19%9.5M
37.36%2.87M
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
Operating revenue
53.24%14.56M
130.40%6.61M
-2.59%3.68M
96.38%2.77M
4.02%1.5M
6.19%9.5M
37.36%2.87M
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
Cost of revenue
-56.29%146K
-57.14%66K
-86.84%5K
-11.36%39K
-63.27%36K
-50.22%334K
-39.84%154K
-77.51%38K
-65.35%44K
-17.65%98K
Gross profit
57.23%14.41M
141.05%6.54M
-1.74%3.68M
99.85%2.73M
8.92%1.47M
10.77%9.17M
48.14%2.71M
247.35%3.74M
-55.97%1.36M
-40.63%1.35M
Operating expense
18.10%36.19M
67.31%13.09M
-1.57%7.46M
6.02%7.67M
-0.45%7.97M
-7.16%30.64M
-4.52%7.82M
-2.58%7.58M
-10.97%7.23M
-10.12%8.01M
Selling and administrative expenses
1.59%18.46M
10.25%4.85M
-4.97%4.19M
4.52%4.56M
-2.80%4.86M
5.02%18.17M
2.64%4.4M
9.13%4.41M
2.68%4.36M
5.78%5M
-General and administrative expense
1.59%18.46M
10.25%4.85M
-4.97%4.19M
4.52%4.56M
-2.80%4.86M
5.02%18.17M
2.64%4.4M
9.13%4.41M
2.68%4.36M
5.78%5M
Research and development costs
42.15%17.73M
140.67%8.24M
3.15%3.27M
8.30%3.11M
3.46%3.11M
-20.59%12.47M
-12.37%3.42M
-15.24%3.17M
-25.95%2.87M
-28.08%3.01M
Operating profit
-1.40%-21.78M
-28.14%-6.55M
1.41%-3.79M
15.80%-4.94M
2.34%-6.51M
13.16%-21.48M
19.68%-5.11M
42.73%-3.84M
-16.78%-5.87M
-0.29%-6.66M
Net non-operating interest income expense
-1.40%1.69M
0.00%393K
-7.81%366K
-1.94%454K
3.46%478K
5.28%1.72M
-2.72%393K
-8.31%397K
21.20%463K
12.68%462K
Non-operating interest income
-1.40%1.69M
0.00%393K
-7.81%366K
-1.94%454K
3.46%478K
5.28%1.72M
-2.72%393K
-8.31%397K
21.20%463K
12.68%462K
Other net income (expense)
-4,240.41%-48.57M
20.56%1.76M
-6,057.47%-26.33M
-6,913.01%-25.88M
624.79%1.88M
758.99%1.17M
17.28%1.46M
149.89%442K
34.22%-369K
-1,536.00%-359K
Gain on sale of security
-1,922.84%-33.6M
-19.37%1.73M
-6,057.47%-26.33M
-2,751.55%-11.06M
676.32%2.07M
355.97%1.84M
72.39%2.15M
149.83%442K
40.03%-388K
16.90%-359K
Special income (charges)
---14.84M
--0
--0
---14.84M
----
--0
--0
--0
--0
----
-Less:Impairment of capital assets
--14.84M
--0
--0
--14.84M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
80.30%-132K
103.92%27K
----
36.84%26K
---185K
-223.62%-670K
-34,350.00%-689K
----
-77.91%19K
----
Income before tax
-269.43%-68.65M
-35.02%-4.39M
-891.40%-29.75M
-425.97%-30.36M
36.83%-4.14M
20.19%-18.58M
31.06%-3.25M
58.07%-3M
-10.96%-5.77M
-5.65%-6.56M
Income tax
-5.28M
0
0
0
0
0
Net income
-241.01%-63.37M
127.45%892K
-891.40%-29.75M
-425.97%-30.36M
36.83%-4.14M
13.49%-18.58M
31.06%-3.25M
58.07%-3M
-10.96%-5.77M
-48.91%-6.56M
Net income continuous Operations
-241.01%-63.37M
127.45%892K
-891.40%-29.75M
-425.97%-30.36M
36.83%-4.14M
13.49%-18.58M
31.06%-3.25M
58.07%-3M
-10.96%-5.77M
-48.91%-6.56M
Minority interest income
514.81%166K
78.26%41K
-12.12%29K
869.23%100K
75.00%-4K
285.71%27K
-62.30%23K
168.75%33K
-150.00%-13K
50.00%-16K
Net income attributable to the parent company
-241.41%-63.53M
126.00%851K
-881.58%-29.78M
-428.89%-30.46M
36.73%-4.14M
13.39%-18.61M
31.46%-3.27M
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-241.41%-63.53M
126.00%851K
-881.58%-29.78M
-428.89%-30.46M
36.73%-4.14M
13.39%-18.61M
31.46%-3.27M
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
Basic earnings per share
-211.11%-0.28
0
-550.00%-0.13
-333.33%-0.13
50.00%-0.02
25.00%-0.09
50.00%-0.01
50.00%-0.02
0.00%-0.03
-33.33%-0.04
Diluted earnings per share
-211.11%-0.28
0
-550.00%-0.13
-333.33%-0.13
50.00%-0.02
25.00%-0.09
50.00%-0.01
50.00%-0.02
0.00%-0.03
-33.33%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 53.24%14.56M130.40%6.61M-2.59%3.68M96.38%2.77M4.02%1.5M6.19%9.5M37.36%2.87M203.29%3.78M-56.34%1.41M-39.48%1.44M
Operating revenue 53.24%14.56M130.40%6.61M-2.59%3.68M96.38%2.77M4.02%1.5M6.19%9.5M37.36%2.87M203.29%3.78M-56.34%1.41M-39.48%1.44M
Cost of revenue -56.29%146K-57.14%66K-86.84%5K-11.36%39K-63.27%36K-50.22%334K-39.84%154K-77.51%38K-65.35%44K-17.65%98K
Gross profit 57.23%14.41M141.05%6.54M-1.74%3.68M99.85%2.73M8.92%1.47M10.77%9.17M48.14%2.71M247.35%3.74M-55.97%1.36M-40.63%1.35M
Operating expense 18.10%36.19M67.31%13.09M-1.57%7.46M6.02%7.67M-0.45%7.97M-7.16%30.64M-4.52%7.82M-2.58%7.58M-10.97%7.23M-10.12%8.01M
Selling and administrative expenses 1.59%18.46M10.25%4.85M-4.97%4.19M4.52%4.56M-2.80%4.86M5.02%18.17M2.64%4.4M9.13%4.41M2.68%4.36M5.78%5M
-General and administrative expense 1.59%18.46M10.25%4.85M-4.97%4.19M4.52%4.56M-2.80%4.86M5.02%18.17M2.64%4.4M9.13%4.41M2.68%4.36M5.78%5M
Research and development costs 42.15%17.73M140.67%8.24M3.15%3.27M8.30%3.11M3.46%3.11M-20.59%12.47M-12.37%3.42M-15.24%3.17M-25.95%2.87M-28.08%3.01M
Operating profit -1.40%-21.78M-28.14%-6.55M1.41%-3.79M15.80%-4.94M2.34%-6.51M13.16%-21.48M19.68%-5.11M42.73%-3.84M-16.78%-5.87M-0.29%-6.66M
Net non-operating interest income expense -1.40%1.69M0.00%393K-7.81%366K-1.94%454K3.46%478K5.28%1.72M-2.72%393K-8.31%397K21.20%463K12.68%462K
Non-operating interest income -1.40%1.69M0.00%393K-7.81%366K-1.94%454K3.46%478K5.28%1.72M-2.72%393K-8.31%397K21.20%463K12.68%462K
Other net income (expense) -4,240.41%-48.57M20.56%1.76M-6,057.47%-26.33M-6,913.01%-25.88M624.79%1.88M758.99%1.17M17.28%1.46M149.89%442K34.22%-369K-1,536.00%-359K
Gain on sale of security -1,922.84%-33.6M-19.37%1.73M-6,057.47%-26.33M-2,751.55%-11.06M676.32%2.07M355.97%1.84M72.39%2.15M149.83%442K40.03%-388K16.90%-359K
Special income (charges) ---14.84M--0--0---14.84M------0--0--0--0----
-Less:Impairment of capital assets --14.84M--0--0--14.84M------0--0--0--0----
Other non- operating income (expenses) 80.30%-132K103.92%27K----36.84%26K---185K-223.62%-670K-34,350.00%-689K-----77.91%19K----
Income before tax -269.43%-68.65M-35.02%-4.39M-891.40%-29.75M-425.97%-30.36M36.83%-4.14M20.19%-18.58M31.06%-3.25M58.07%-3M-10.96%-5.77M-5.65%-6.56M
Income tax -5.28M00000
Net income -241.01%-63.37M127.45%892K-891.40%-29.75M-425.97%-30.36M36.83%-4.14M13.49%-18.58M31.06%-3.25M58.07%-3M-10.96%-5.77M-48.91%-6.56M
Net income continuous Operations -241.01%-63.37M127.45%892K-891.40%-29.75M-425.97%-30.36M36.83%-4.14M13.49%-18.58M31.06%-3.25M58.07%-3M-10.96%-5.77M-48.91%-6.56M
Minority interest income 514.81%166K78.26%41K-12.12%29K869.23%100K75.00%-4K285.71%27K-62.30%23K168.75%33K-150.00%-13K50.00%-16K
Net income attributable to the parent company -241.41%-63.53M126.00%851K-881.58%-29.78M-428.89%-30.46M36.73%-4.14M13.39%-18.61M31.46%-3.27M57.33%-3.03M-10.15%-5.76M-49.63%-6.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -241.41%-63.53M126.00%851K-881.58%-29.78M-428.89%-30.46M36.73%-4.14M13.39%-18.61M31.46%-3.27M57.33%-3.03M-10.15%-5.76M-49.63%-6.54M
Basic earnings per share -211.11%-0.280-550.00%-0.13-333.33%-0.1350.00%-0.0225.00%-0.0950.00%-0.0150.00%-0.020.00%-0.03-33.33%-0.04
Diluted earnings per share -211.11%-0.280-550.00%-0.13-333.33%-0.1350.00%-0.0225.00%-0.0950.00%-0.0150.00%-0.020.00%-0.03-33.33%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -